Abstract
It is well known that the regulation of muscle contraction relies on the ability of tropomyosin to switch between different positions on the actin filament, but it is still not well understood which amino acids are directly involved in the different states of the interaction. Recently the structure of the actin–tropomyosin interface has been determined both in the absence and presence of myosin heads. Interestingly, a number of mutations in tropomyosin that are associated with skeletal muscle myopathy are located within this interface. We first give an overview of the functional effect of mutations on amino acids that are involved in the contact with actin asp25, which represent a pattern repeated seven times along tropomyosin. It is explained how some of these amino acids (R167 and R244) which are thought to be involved in a salt bridge contact with actin in the closed state can produce a loss-of-function when mutated, while other positively charged tropomyosin amino acids positioned on the downstream side of the contact (K7, K49, R91, K168) can produce a gain-of-function when mutated. We then consider mutations of amino acids involved in another salt bridge contact between the two proteins in the closed state, actin K326N (which binds on five different points of tropomyosin) and tropomyosin ∆E139 and E181K, and we report how all of these mutations produce a gain-of-function. These observations can be important to validate the proposed structures and to understand more deeply how mutations affect the function of these proteins and to enable prediction of their outcomes.
Similar content being viewed by others
References
Barua B, Fagnant PM, Winkelmann DA, Trybus KM, Hitchcock-Degregori SE (2013) A periodic pattern of evolutionarily conserved basic and acidic residues constitutes the binding interface of actin–tropomyosin. J Biol Chem 288:9602–9609
Behrmann E, Müller M, Penczek PA, Mannherz HG, Manstein DJ, Raunser S (2012) Structure of the rigor actin–tropomyosin–myosin complex. Cell 150:327–338
Brown JH, Zhou Z, Reshetnikova L, Robinson H, Yammani RD, Tobacman LS, Cohen C (2005) Structure of the mid-region of tropomyosin: bending and binding sites for actin. Proc Natl Acad Sci USA 102:18878–18883
Clarke NF, Kolski H, Dye DE, Lim E, Smith RLL, Patel R, Fahey MC, Bellance R, Romero NB, Johnson ES, Labarre-Vila A, Monnier N, Laing NG, North KN (2008) Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 63:329–337
Clarke NF, Domazetovska A, Waddell L, Kornberg A, Mclean C, North KN (2009) Cap disease due to mutation of the beta-tropomyosin gene (TPM2). Neuromuscul Disord 19:348–351
Clarke NF, Waddell LB, Sie LTL, van Bon BWM, Mclean C, Clark D, Kornberg A, Lammens M, North KN (2012) Mutations in TPM2 and congenital fibre type disproportion. Neuromuscul Disord 22:955–958
Davidson AE, Siddiqui FM, Lopez MA, Lunt P, Carlson HA, Moore BE, Love S, Born DE, Roper H, Majumdar A, Jayadev S, Underhill HR, Smith CO, von der Hagen M, Hubner A, Jardine P, Merrison A, Curtis E, Cullup T, Jungbluth H, Cox MO, Winder TL, Abdel Salam H, Li JZ, Moore SA, Dowling JJ (2013) Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. Brain 136:508–521
Donner K, Ollikainen M, Ridanpää M, Christen H-J, Goebel HH, de Visser M, Pelin K, Wallgren-Pettersson C (2002) Mutations in the beta-tropomyosin (TPM2) gene–a rare cause of nemaline myopathy. Neuromuscul Disord 12:151–158
Feng JJ, Marston S (2009) Genotype-phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromusc Disord 19:6–16
Frye J, Klenchin VA, Rayment I (2010) Structure of the tropomyosin overlap complex from chicken smooth muscle: insight into the diversity of N-terminal recognition. Biochemistry 49:4908–4920
Greenfield NJ, Huang YJ, Swapna GV, Bhattacharya A, Rapp B, Singh A, Montelione GT, Hitchcock-DeGregori SE (2006) Solution NMR structure of the junction between tropomyosin molecules: implications for actin binding and regulation. J Mol Biol 364:80–96
Holmes KC, Lehman W (2008) Gestalt-binding of tropomyosin to actin filaments. J Muscle Res Cell Motil 29:213–219
Jain RK, Jayawant S, Squier W, Muntoni F, Sewry CA, Manzur A, Quinlivan R, Lillis S, Jungbluth H, Sparrow JC, Ravenscroft G, Nowak KJ, Memo M, Marston SB, Laing NG (2012) Nemaline myopathy with stiffness and hypertonia associated with an ACTA1 mutation. Neurology 78:1100–1103
Jarraya M, Quijano-Roy S, Monnier N, Béhin A, Avila-Smirnov D, Romero NB, Allamand V, Richard P, Barois A, May A, Estournet B, Mercuri E, Carlier PG, Carlier R-Y (2012) Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations. Neuromuscul Disord 22:S137–S147
Kiphuth IC, Krause S, Huttner HB, Dekomien G, Struffert T, Schröder R (2010) Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation. J Neurol 257:658–660
Laing NG, Nowak KJ (2005) When contractile proteins go bad: the sarcomere and skeletal muscle disease. BioEssays 27:809–822
Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, Blumbergs P, White S, Watkins H, Love DR (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 10:249
Lehman W, Orzechowski M, Li XE, Fischer S, Raunser S (2013) Gestalt-Binding of tropomyosin on actin during thin filament activation. J Muscle Res Cell Motil. doi:10.1007/s10974-013-9342-0
Lehtokari V-L, Ceuterick-de Groote C, de Jonghe P, Marttila M, Laing NG, Pelin K, Wallgren-Pettersson C (2007) Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2. Neuromuscul Disord 17:433–442
Li XE, Tobacman LS, Mun JY, Craig R, Fischer S, Lehman W (2011) Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry. Biophys J 100:1005–1013
Marston SB, Lehman W, Li X, Memo M (2013) A repeating structural motif in tropomyosin that is responsible for multiple gain of function skeletal myopathy mutations. Biophys J 104:646a–647a
Marttila M, Lemola E, Wallefeld W, Memo M, Donner K, Laing NG, Marston S, Grönholm M, Wallgren-Pettersson C (2012) Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy. Biochem J 442:231–239
McLachlan AD, Stewart M (1976) The 14-fold periodicity in alpha-tropomyosin and the interaction with actin. J Mol Biol 103:271–298
Memo, M. 2012. Molecular mechanisms of myopathies. PhD thesis, Imperial College London
Mokbel N, Ilkovski B, Kreissl M, Memo M, Jeffries CM, Marttila M, Lehtokari VL, Lemola E, Gronholm M, Yang N, Menard D, Marcorelles P, Echaniz-Laguna A, Reimann J, Vainzof M, Monnier N, Ravenscroft G, McNamara E, Nowak KJ, Laing NG, Wallgren-Pettersson C, Trewhella J, Marston S, Ottenheijm C, North KN, Clarke NF (2013) K7del is a common TPM2 gene mutation associated with nemaline myopathy and raised myofibre calcium sensitivity. Brain 136:494–507
Ochala, J, Li M, Ohlsson M, Oldfors A, Larson L (2008) Defective regulation of contractile function in muscle fibres carrying an E41K β-tropomyosin mutation. J Physiol 586:2993–3004
Ochala J, Gokhin DS, Pénisson-Besnier I, Quijano-Roy S, Monnier N, Lunardi J, Romero NB, Fowler VM (2012) Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms. Hum Mol Genet 21:4473–4485
Orzechowski M, Fischer S, Lehman W et al (2013) Influence of actin mutation on the energy landscape of actin–tropomyosin filaments. Biophys J 104:480a
Palm T, Graboski S, Hitchcock-DeGregori SE, Greenfield NJ (2001) Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J 81:2827–2837
Robinson P, Lipscomb S, Preston LC, Altin E, Watkins H, Ashley CC, Redwood CS (2007) Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function. FASEB J. 21:896–905
Tajsharghi H, Ohlsson M, Palm L, Oldfors A (2012) Myopathies associated with β-tropomyosin mutations. Neuromuscul Disord 22:923–933
Tan P, Briner J, Boltshauser E, Davis MR, Wilton SD, North K, Wallgren-Pettersson C, Laing NG (1999) Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 9:573–579
Acknowledgments
This work was supported by grants from The British Heart Foundation (RG/11/20/29266 and FS/07/057/23834).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Memo, M., Marston, S. Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function. J Muscle Res Cell Motil 34, 165–169 (2013). https://doi.org/10.1007/s10974-013-9344-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-013-9344-y